


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.58%
+5.13%
+0.49%
-14.24%
ACRS
Aclaris Therapeutics
$3.54
ACRS Price Performance
$3.26 (+8.59%)
$3.03 (+16.83%)
$2.01 (+76.12%)
$1.53 (+131.37%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
ACRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ACRS Street Sentiment is bullish and have negative views on the near-term outlook
ACRS has Fair risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Oct 20, 2025
Reiterate
Buy
HC Wainwright & Co.
SNY
Sanofi
43.60
-0.07%
PFE
Pfizer
26.58
-1.04%
LLY
Eli Lilly and
985.08
+0.80%
ABBV
AbbVie
219.68
-2.52%
What is ACRS current stock price?
What are ACRS stock strengths?
What is ACRS Risk Level?
What is ACRS market cap and volume?
What is ACRS current Stock IQ?
Should I buy ACRS stock right now?
Is ACRS a Strong Buy right now?
What does a 'Strong Buy' rating mean for ACRS?
What does a 'Strong Sell' rating mean for ACRS?
What factors influence ACRS's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ACRS
Aclaris Therapeutics
Current Price
$3.54
Runners Also Watch
SNY
Sanofi
43.60
-0.07%
PFE
Pfizer
26.58
-1.04%
LLY
Eli Lilly and
985.08
+0.80%
ABBV
AbbVie
219.68
-2.52%

ACRS Price Performance
$3.26 (+8.59%)
$3.03 (+16.83%)
$2.01 (+76.12%)
$1.53 (+131.37%)
ACRS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
ACRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ACRS Street Sentiment is bullish and have negative views on the near-term outlook
ACRS has Fair risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
ACRS Stock IQ
Stock Insights
Not Enough Information
ACRS Latest Analysis
Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference. WAYNE Pa. March 03 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics Inc. (NASDAQ:ACRS) a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases today announced that on Tuesday March 10 2026 at 1:40 PM EDT Aclaris'. Chief Executive Officer Dr. Neal Walker and other members of Aclaris'. senior leadership team will participate in a fir
Tue Mar 3, 2026
Aclaris Therapeutics GAAP EPS of -$0.16 misses by $0.02 revenue of $1.3M misses by $0.77M.
Thu Feb 26, 2026
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052. Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
Tue Feb 24, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ACRS Stock trends
ACRS Stock performance
ACRS Stock analysis
ACRS investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.